Orkila Capital
Private equity
Active
New York, United States
5
200M
3
0.56
2
0.40
1
- Areas of investment
Summary
Orkila Capital appeared to be the VC, which was created in 2013. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the New York.
Among the most popular portfolio startups of the fund, we may highlight Cannamedical Pharma. For fund there is no match between the location of its establishment and the land of its numerous investments - Germany. Among the most popular fund investment industries, there are Medical, Brewing. Besides, a startup needs to be aged 2-3 years to get the investment from the fund.
The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. Deals in the range of 10 - 50 millions dollars are the general things for fund.
The usual cause for the fund is to invest in rounds with 1 partaker.
This organization was formed by Jesse M. Du Bey.
Investor highlights
- Industry focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 5
- Lead investments
- 2
- Exits
- 1
- Rounds per year
- 0.56
- Follow on index
- 0.40
- Investments by industry
- Wellness (3)
- Nutrition (3)
- Food and Beverage (3)
- Medical (1)
- Cannabis (1) Show 3 more
- Investments by region
-
- Sweden (3)
- Germany (1)
- Denmark (1)
- Peak activity year
- 2020
- Number of Unicorns
- 1
- Number of Decacorns
- 1
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 17
- Avg. valuation at time of investment
- 600M
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Cannamedical Pharma | 31 Jan 2019 | Medical, Pharmaceutical, Cannabis | Early Stage Venture | 17M | North Rhine-Westphalia, Cologne, Germany |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.